PharmaIN, Corp.
Biotechnology ResearchWashington, United States11-50 Employees
PharmaIN is a clinical-stage biopharmaceutical company dedicated to developing first- and best-in-class subcutaneous therapies through peptide engineering.
Innovative Therapeutics PharmaIN specializes in developing first- and best-in-class subcutaneous therapies through peptide engineering, indicating strong potential for collaborations in advanced biologics and personalized medicine markets.
Strategic Partnerships The recent collaboration with NanoTemper Technologies highlights PharmaIN's active engagement in innovative research and technology partnerships, creating opportunities for joint development and co-marketing initiatives.
Growth Potential With revenue in the $10M to $25M range and recent funding of $1.5M, PharmaIN is at a growth stage that may require specialized solutions in biotechnology R&D, clinical development, and regulatory compliance support.
Technology Emphasis The company's use of diverse tech stack elements such as open graph, SEO tools, and web platforms suggests a focus on digital engagement and marketing automation, presenting opportunities for sales in digital tools and SaaS solutions.
Market Position Being a clinical-stage biotech with a relatively small team, PharmaIN could be receptive to innovative, scalable technology solutions, contracts, or services that streamline research processes or enhance operational efficiency.
PharmaIN, Corp. uses 8 technology products and services including Open Graph, Slider Revolution, Smartsheet, and more. Explore PharmaIN, Corp.'s tech stack below.
| PharmaIN, Corp. Email Formats | Percentage |
| FLast@pharmain.com | 76% |
| Last@pharmain.com | 16% |
| First.Last@pharmain.com | 5% |
| First-Last@pharmain.com | 3% |
Biotechnology ResearchWashington, United States11-50 Employees
PharmaIN is a clinical-stage biopharmaceutical company dedicated to developing first- and best-in-class subcutaneous therapies through peptide engineering.
PharmaIN, Corp. has raised a total of $1.5M of funding over 1 rounds. Their latest funding round was raised on May 16, 2014 in the amount of $1.5M.
PharmaIN, Corp.'s revenue is estimated to be in the range of $10M$25M
PharmaIN, Corp. has raised a total of $1.5M of funding over 1 rounds. Their latest funding round was raised on May 16, 2014 in the amount of $1.5M.
PharmaIN, Corp.'s revenue is estimated to be in the range of $10M$25M